From humble roots to noble humanitarian cause, PCR has left an indelible impact on the world of science.
Innovations to confront the challenges of viral vaccine research today and tomorrow
Here are a few notable developments that will continue to advance our understanding of COVID-19 throughout 2021 and beyond.
Researchers have begun to dissect SARS-CoV-2 effects on the blood brain barrier, making use of innovative cell culture models, techniques, and equipment
The successful application of NGS technologies to a problem of this scale and scope speaks to the power of innovation. Here are a few new NGS solutions for COVID-19 research applications.
Mass spectrometry once again wields its might, combating the COVID-19 pandemic from multiple aspects. Here is a brief look at some of the method development and collaborative efforts that are leading the charge.
New products and technologies are helping to arm scientists and medical professionals – providing the insight needed in the fight against this unprecedented viral disease.
Understanding the strengths and limitations of real-time RT-PCR is essential for examining the current virus outbreak and for those that may emerge in the future.
Bold innovations in sample collection, point of care detection, immunity profiling and other applications are adding new firepower in the fight against COVID-19.
Detecting invasion by the SARS-COV-2 virus (the causative agent of COVID-19) is the crucial first step in identifying pathogen exposure. Measuring the human immune response is the vital next stage to quantify true infection rates and to decipher the development of immunity.
Companies have stepped forward with innovative products in the areas of personal protective equipment, testing and diagnostics, safety and automation, and others in the fight against the COVID-19 pandemic.
The Emerging Trends in Infectious Disease Interactive Infographic is a living resource -- this post serves as a chronology of the infographic, citing ongoing developments in the areas of: Detection and Containment, Diagnosis and Treatment, Laboratory Equipment, and Prevention and Surveillance.
The Virus Surface to a Novel COVID-19 Vaccine Candidate: The Journey of the SARS-CoV-2 Spike Protein
Intensive analysis of the spike protein led to the development of the first vaccine candidate approved for clinical trials. Perhaps overshadowed, is the unprecedented collaboration between academic scientists, government institutions, and private industry central to this remarkable work.
Challenges with the approval of COVID-19 test diagnostics uncovered serious process issues that are now being resolved in order to contain the current outbreak and to fight future pathogens.